GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofrontera AG (XTER:B8F) » Definitions » FCF Yield %

Biofrontera AG (XTER:B8F) FCF Yield % : -22.34 (As of May. 12, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Biofrontera AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Biofrontera AG's Trailing 12-Month Free Cash Flow is €-4.88 Mil, and Market Cap is €21.82 Mil. Therefore, Biofrontera AG's FCF Yield % for today is -22.34%.

The historical rank and industry rank for Biofrontera AG's FCF Yield % or its related term are showing as below:

XTER:B8F' s FCF Yield % Range Over the Past 10 Years
Min: -26.94   Med: -11.46   Max: -0.36
Current: -22.34


During the past 13 years, the highest FCF Yield % of Biofrontera AG was -0.36%. The lowest was -26.94%. And the median was -11.46%.

XTER:B8F's FCF Yield % is ranked worse than
84.41% of 1084 companies
in the Drug Manufacturers industry
Industry Median: -0.635 vs XTER:B8F: -22.34

Biofrontera AG's FCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.


Biofrontera AG FCF Yield % Historical Data

The historical data trend for Biofrontera AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofrontera AG FCF Yield % Chart

Biofrontera AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.24 -16.84 -2.49 35.51 -5.01

Biofrontera AG Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biofrontera AG's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Biofrontera AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofrontera AG's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofrontera AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Biofrontera AG's FCF Yield % falls into.



Biofrontera AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Biofrontera AG's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.876 / 97.3058275
=-5.01%

Biofrontera AG's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 35.093905
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biofrontera AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Biofrontera AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of Biofrontera AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofrontera AG (XTER:B8F) Business Description

Traded in Other Exchanges
Address
Hemmelrather Weg 201, Leverkusen, NW, DEU, 51377
Biofrontera AG is active in the field of healthcare. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.

Biofrontera AG (XTER:B8F) Headlines

No Headlines